Serum growth hormone-binding protein in obesity: Effect of a short-term, very low calorie diet and diet-induced weight loss

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 4, 1996, Pages 1519-1524

  Rasmussen, Michael Højby ^a,c   Ho, Ken K Y ^b   Kjems, Lise ^a   Hilsted, Jannik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ST VINCENT S HOSPITAL   (Australia)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; PROINSULIN;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BINDING; REGRESSION ANALYSIS; WEIGHT REDUCTION;

ADULT; ANTHROPOMETRY; BODY MASS INDEX; CARRIER PROTEINS; DIET, REDUCING; FEMALE; GROWTH HORMONE; HUMANS; INSULIN; MALE; OBESITY; PROINSULIN; REFERENCE VALUES; REGRESSION ANALYSIS; WEIGHT LOSS;

EID: 0029964173     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.4.1519     Document Type: Article

References (33)

1. Baumann G, Stolar M, Amburn K, Barsano C, DeVries N. 1986 A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab. 62:134-141.
2. Leung DW, Spencer SA, Cachianes G, et al. 1987 Growth hormone receptor and serum binding protein: purification, cloning, and expression. Nature. 330:537-543.
3. Baumann G, Shaw MA, Ambum K. 1994 Circulating growth hormone binding proteins. J Endocrinol Invest. 17:67-81.
4. Glass AR. 1989 Endocrine aspects of obesity. Med Clin North Am. 73:139-160.
5. Veldhuis JD, Iranmanesh A, Ho KKY, Waters MJ, Johnson ML, Lizarralde G. 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatropism of obesity in man. J Clin Endocrinol Metab. 72:51-59.
6. Mårin P, Kvist H, Lindstedt G, Sjöström L, Björntorp P. 1993 Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obesity. 17:83-89.
7. Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. 1994 The impact of obesity, fat distribution and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin and growth hormone. Metabolism. 43:315-319.
8. Holl RW, Snehotta R, Scherbaum W, Heintz E. 1991 Binding protein for human growth hormone: effects of age and weight. Horm Res. 35:190-197.
9. Hochberg Z, Hertz P, Colin V, et al. 1992 The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism. 41:106-112.
10. Silbergeld A, Lazar L, Erster B, Keret R, Tepper R, Laron Z. 1989 Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlations with age, height and weight. Clin Endocrinol (Oxf). 31:295-303.
11. Martha Jr PM, Rogol AD, Blizzard RM, Shaw MA, Baumann G. 1991 Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys. J Clin Endocrinol Metab. 73:175-181.
12. Rajkovic IA, Valiontis E, Ho KKY. 1994 Direct quantitation of growth hormone binding protein in human serum by ligand immunofunctional assay: comparison with immunoprecipitation and chromatographic methods. J Clin Endocrinol Metab. 78:772-777.
13. Baumann G, Shaw MA, Merimee TJ, Clemmons DR. 1988 Growth hormone-binding protein in human plasma: downregulation by prolonged fasting in lean but not obese subjects [Abstract]. Clin Res. 36:477A.
14. Baxter RC, Brown AS, Turtle JR. 1980 Association between serum insulin, serum somatomedin and liver receptors for human growth hormone in streptozotocin diabetes. Horm Metab Res. 12:377-381.
15. Mercado M, Mollitch ME, Baumann G. 1992 Low plasma growth hormone binding protein in IDDM. Diabetes. 41:605-609.
16. Reaven GM, Chen Y-DI, Hollenbeck CB, Sheu WHH, Ostrega D, Polonsky KS. 1993 Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab. 76:44-48.
17. Rasmussen MH, Juul A, Kjems LL, Skakkebæk NE, Hilsted J. 1995 Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J Clin Endocrinol Metab. 80:796-801.
18. National Research Council. 1989 Recommended dietary allowances, 10th ed. Washington DC: National Academy Press.
19. Hey H, Petersen HD, Andersen T, Quaade F. 1986 Formula diet plus free additional food choice up to 1000 kcal (4.2 MJ) compared with an isoenergetic conventional diet in the treatment of obesity. A randomised clinical trial. Clin Nutr. 6:195-199.
20. Kowarski A, Thompson RG, Migeon CJ, Blizzard RM. 1971 Determination of integrated plasma concentrations and true secretion rates of human growth hormone. J Clin Endocrinol Metab. 32:356-360.
21. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Røder ME. 1993 Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 39: 578-582.
22. Kjems LL, Roder ME, Dinesen B, Hartling SG, Jørgensen PN, Binder C. 1993 Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem. 39:2146-2150.
23. Meriam GR, Watcher KW. 1982 Algorithms for the study of episodic hormone secretion. Am J Physiol. 243:E310-E318.
24. Rasmussen MH, Andersen T, Breum L, Hilsted J, Gøtzsche PC. 1993 Observer variation in measurements of waist to hip ratio and the abdominal sagittal diameter. Int J Obesity. 17:323-327.
25. Rasmussen MH, Andersen T, Breum L, Gøtzsche PC, Hilsted J. 1993 Cimetidine suspension as adjuvant to energy restricted diet in treating obesity. Br Med J. 306:1093-1096.
26. Rasmussen MH, Hvidberg A, Juul A, et al. 1995 Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-1 levels in obese subjects. J Clin Endocrinol Metab. 80:1407-1415.
27. Gotfredsen A, Hilsted J. 1994 Accuracy of body composition measurements by dual energy x-ray absorptiometry (DXA). Bone Miner. 25(Suppl 2):33.
28. Stern MP, Haffner SM. 1986 Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis. 6:123-130.
29. Peiris AN, Sothman MS, Hoffmann RG, et al. 1989 Adiposity, fat distribution and cardiovascular risk. Ann Intern Med. 110:867-872.
30. Baxter RC, Turtle JR. 1978 Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun. 84:350-357.
31. Baumann G, Amburn KD, Buchanan TA. 1987 The effect of circulating growth hormone-binding protein on metabolic clerance, distribution, and degradation of human growth hormone. J Clin Endocrinol Metab. 64:657-660.
32. Flier JS, Cook KS, Usher P, Spigelman BM. 1987 Severely impaired adipsin expression in genetic and acquired obesity. Science. 237:405-408.
33. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse obese gene and its human homoloque. Nature. 372:425-432.